Pavmed
Pavmed Inc., a pioneering medical technology company headquartered in the United States, was founded in 2014. The company focuses on developing innovative solutions across various medical fields, including gastroenterology, urology, and general surgery. With a commitment to enhancing patient care, Pavmed has introduced unique products such as the EsoGuard® and the CarpX® device, which stand out for their advanced design and efficacy. Operating primarily in the US, Pavmed has achieved significant milestones, including successful clinical trials and regulatory approvals that underscore its market position. The company is dedicated to addressing unmet medical needs, making it a notable player in the medical device industry. With a strong emphasis on innovation and patient outcomes, Pavmed continues to shape the future of healthcare technology.
DitchCarbon Score
How does Pavmed's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pavmed's score of 5 is lower than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pavmed's reported carbon emissions
In 2023, Pavmed reported total carbon emissions of approximately 115,790 kg CO2e, an increase from about 97,620 kg CO2e in 2022. The emissions breakdown for 2023 includes about 65,440 kg CO2e from Scope 1 and approximately 50,350 kg CO2e from Scope 2. This indicates a rise in both direct and indirect emissions compared to the previous year. Pavmed has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of documented climate pledges or commitments suggests that the company may still be in the early stages of formalising its climate strategy. As the industry increasingly prioritises sustainability, Pavmed's future commitments will be crucial in aligning with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 61,200 | 00,000 |
| Scope 2 | 36,420 | 00,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pavmed is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
